E
HCW Biologics Inc. HCWB
$6.02 $0.132.21% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 87.38% 70.58% 68.42% 20.98% -254.99%
Total Depreciation and Amortization 124.71% 72.07% 148.54% -53.73% -54.31%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -767.85% 74.21% -94.70% 30.12% 57.87%
Change in Net Operating Assets -100.45% -164.02% -143.60% 155.56% 281.91%
Cash from Operations 32.49% 2.50% 27.21% 47.64% 48.23%
Capital Expenditure -- -- 96.95% 94.11% 101.19%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- 96.95% -100.40% 101.19%
Total Debt Issued -92.31% -- -- -- --
Total Debt Repaid -6.19% -9.43% -5.80% -228.89% --
Issuance of Common Stock -- -99.93% 49,319.29% -100.00% -100.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 140.18% -101.26% 43,398.04% 31,565.17% 24,846.75%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 145.55% -829.45% 148.21% -104.32% 73.28%